Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI.
Pietro ZaraValentina FlorisEoin Patrick FlanaganAlfonso Sebastian Lopez-ChiribogaBrian G WeinshenkerPaolo SollaElia SechiPublished in: Multiple sclerosis journal - experimental, translational and clinical (2021)
MOG-IgG-positivity is unlikely to alter the expected treatment response and outcomes in patients with otherwise typical MS phenotype on MRI.